Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Holding FOLD?
Track your performance easily

Amicus (FOLD) Technical Analysis

921 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Amicus Therapeutics is a Buy.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 11.29, while Amicus Therapeutics’s (FOLD) share price is $11.01, making it a Sell.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 11.06, while Amicus Therapeutics’s (FOLD) share price is $11.01, making it a Sell.

Amicus (FOLD) Pivot Points

Sep 20, 2024, 12:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.73
10.89
11.04
11.20
11.36
11.52
11.67
Fibonacci
10.89
11.01
11.08
11.20
11.33
11.40
11.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Sep 20, 2024, 12:02 AM
Period
Simple
Exponential
MA5
11.15Sell
11.12Sell
MA10
11.31Sell
11.24Sell
MA20
11.45Sell
11.29Sell
MA50
10.99Sell
11.06Sell
MA100
10.47Buy
10.93Sell
MA200
11.43Sell
11.28Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 11.24, while Amicus Therapeutics’s (FOLD) share price is $11.01, making it a Sell.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 10.93, while Amicus Therapeutics’s (FOLD) share price is $11.01, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $11.01 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 10.99, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $11.01 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 10.47, creating a Buy signal.
Amicus Therapeutics’s (FOLD) stock price is $11.01 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 11.43, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Sep 20, 2024, 12:02 AM
Name
Value
Implied Action
RSI (14)
41.78
Neutral
STOCH (9,6)
9.22
Buy
STOCHRSI (14)
8.51
Buy
MACD (12,26)
0.01
Buy
ADX (14)
15.63
Buy
Williams %R
-98.17
Buy
CCI (14)
-136.42
Buy
ATR (14)
0.34
-
Ultimate Oscillator
37.96
Neutral
ROC
-2.68
Sell
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 41.78, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 15.63, creating a Buy signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is -136.42, creating a Buy signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is -2.68, creating a Sell signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Sell.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 41.78, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is 0.01, which suggests FOLD is a Buy.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 11.15, which suggests FOLD is a Sell.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 11.45, which suggests FOLD is a Sell.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 10.99, which suggests FOLD is a Sell.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 11.43, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -98.17, which suggests FOLD is a Buy.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is -136.42, which suggests FOLD is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis